RBI examines Lupin’s proposal to increase FII limit to 49%

17 Oct 2013 Evaluate

The Reserve Bank of India (RBI) is studying the proposal submitted by Lupin for increasing the Foreign Institutional Investors (FIIs) shareholding limit from 33% to 49%. The company has applied to RBI for its approval pursuant to the resolution passed at the last Annual General Meeting (AGM) for the same.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

Lupin Share Price

2126.00 -21.60 (-1.01%)
28-Jan-2026 13:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1614.10
Dr. Reddys Lab 1224.25
Cipla 1317.35
Zydus Lifesciences 892.45
Lupin 2126.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×